source
- Novo Nordisk sues Eli Lilly, alleging deceptive ads that misrepresent GLP-1 drug efficacyNovo Nordisk filed a lawsuit in federal court in New Jersey accusing Eli Lilly of running a deceptive advertising campaign. The complaint says Lilly’s ads compare the highest doses of its weight‑l…
- Rare-disease biotech coalition urges Trump admin to carve out orphan drugs from Medicare price-cut pilotsBiotech firms formed the Rare Disease Company Coalition and met with the White House Office of Management and Budget to discuss excluding orphan drugs from two Medicare price‑cut pilot programs. T…